A study of dermatological efficacy of topical product(BSL02-150929Y) in human skin
Phase of Trial: Phase I
Latest Information Update: 03 Oct 2016
At a glance
- Drugs BSL 02-150929Y (Primary)
- Indications Erythema
- Focus Therapeutic Use
- Sponsors Kao Corporation
- 29 Sep 2016 Status changed from active, no longer recruiting to completed.
- 12 Nov 2015 Status changed from recruiting to active, no longer recruiting, as reported by University Hospital Medical Information Network - Japan record.
- 30 Oct 2015 New trial record